Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene

Human Genetics

Volumn 99, Issue 1, 1996, Pages 88-92

  Upadhyaya, Meena ^a   Osborn, Michael J ^a   Maynard, Julie ^a   Kim, Mee Rhan ^b   Tamanoi, Fuyuhiko ^b   Cooper, David N ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MUTANT PROTEIN; NEUROFIBROMIN;

ARTICLE; CHROMOSOME 17Q; GENETIC SCREENING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEUROFIBROMATOSIS; NONSENSE MUTATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0031060683     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050317     Document Type: Article

References (25)

1. Andrews JD, Mancini DN, Singh SM, Rodenheiser DI (1996) Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31. Hum Mol Genet 5: 503-507
2. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63: 851-859
3. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715
4. Buchberg AM, Cleveland LS, Jenkins MA, Copeland NG (1990) Sequence homology shared by neurofibromatosis type 1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347: 291-294
5. Cooper DN, Krawczak M (1996) Human gene mutation database. http://www.cf.ac.uk/uwcm/mg/hgmd0.html
6. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N (1992) The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neurone 8: 415-419
7. Easton DF, Ponder MA, Huson SM, Ponder BAJ (1993) An analysis of variation in expression of neurofibromatosis type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53: 305-313
8. Gutmann DH, Collins FS (1995) Von Recklinghausen neurofibromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 677-696
9. Gutmann DH, Boguski M, Marchuk D, Wigler M, Collins FS, Ballester R (1993) Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site directed mutagenesis. Oncogene 8: 761-769
10. Heim RA, Kam-Morgan LNW, Birrie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silverman LM, Luce MC (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4: 975-981
11. Huson SM, Hughes RAC (1994) The neurofibromatoses: a clinical and pathogenetic overview. Chapman and Hall, London
12. ras, inhibition of cell proliferation and morphological changes. Oncogene 11: 325-335
13. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3: 122-126
14. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samouritz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumours. Cell 69: 275-281
15. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Shannon N, Robertson M, White R, Viskochil D (1995) Genomic organisation of the neurofibromatosis 1 gene (NF1). Genomics 25: 9-18
16. Lowy DR, Johnson MR, DeClue JE, Cen H, Zhang K, Papageorge AG, Vass WC, Williamsen BM, Valentine MB, Look AT (1993) Cell transformation by ras and regulation of its protein product. Ciba Found Symp 176: 67-80
17. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, Gutmann DH, Boguski M, Collins FS (1991) cDNA cloning of the type1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11: 931-940
18. 21.Cell 63: 843-849
19. Morcos P, Thapar N, Tusneem N, Stacey D, Tamanoi F (1996) Identification of neurofibromin mutants that exhibit allele-specificity or increased Ras affinity resulting in suppression of activated Ras alleles. Mol Cell Biol 16: 2496-2503
20. val-19 activated phenotypes. Mol Cell Biol 14: 815-821
21. Purandare SM, Lanyon WG, Connor JM (1994) Characterisation of inherited and sporadic mutations in neurofibromatosis type 1. Hum Mol Genet 3: 1109-1115
22. Shen MH, Harper PS, Upadhyaya M (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33: 2-17
23. Upadhyaya M, Maynard J, Osborn MJ, Huson SM, Ponder M, Ponder BAJ, Harper PS (1995) Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. J Med Genet 32: 706-710
24. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF (1995) Loss of neurofibromin results in neutrophin independent survival of embryonic sensory and 8 sympathetic neurones. Cell 82: 733-742
25. Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements IRA mutants of S. cerevisiae. Cell 63: 835-841